Ahuja, K.
Vandenabeele, M.
Nami, F.
Lefevere, E.
Van hoecke, J.
Bergmans, S.
Claes, M.
Vervliet, T.
Neyrinck, K.
Burg, T.
De Herdt, D.
Bhaskar, P.
Zhu, Y.
Looser, Z. J.
Loncke, J.
Gsell, W.
Plaas, M.
Agostinis, P.
Swinnen, J. V.
Van Den Bosch, L.
Bultynck, G.
Saab, A. S.
Wolfs, E.
Chai, Y. C.
Himmelreich, U.
Verfaillie, C.
Moons, L.
De Groef, L.
Funding for this research was provided by:
Central Europe Leuven Strategic Alliance (CELSA/20/009, CELSA/20/009, CELSA/20/009)
Queen Elisabeth Medical Foundation (Queen Elisabeth Medical Foundation, Queen Elisabeth Medical Foundation)
Research Foundation Flanders (G081821N, Research Foundation Flanders, Research Foundation Flanders, Research Foundation Flanders, Research Foundation Flanders, Research Foundation Flanders, Research Foundation Flanders)
Life Science Research Partners (Life Science Research Partners, Life Science Research Partners, Life Science Research Partners)
Eye Hope Foundation (Eye Hope Foundation, Eye Hope Foundation, Eye Hope Foundation)
Article History
Received: 29 April 2024
Accepted: 18 July 2024
First Online: 28 August 2024
Declarations
:
: All animal experiments were performed according to the European directive 2010/63/EU and approved by the KU Leuven institutional ethics committee for animal research (project no. P068/2018). All human iPSC studies were done after approval by the KU Leuven institutional ethics committee (project no. S50354).
: Not applicable.
: The authors declare that they have no competing interests.